Summer Sale Extended! Get unlimited digital access for 13 weeks for $13.
Topics

Food and Drug Administration

FDA: Olympus waited years to report scope problems

FDA: Olympus waited years to report scope problems

WASHINGTON — Federal regulators have uncovered new violations by the manufacturer of medical scopes recently linked to outbreaks of deadly "superbug" bacteria at U.S. hospitals. Olympus Corp., which has its U.S. headquarters and 950 employees in Upper Saucon Township, failed to alert regulators to a cluster of 16 infections in patients who underwent procedures with the company's scope in 2012, according to a warning letter posted online Monday by the Food and Drug Administration. Olympus did not report the problems to the FDA until 2015, when the company was already under scrutiny for a more recent series of outbreaks. Medical device manufacturers are required to...

Loading
75°